ロード中...

Docetaxel-Related Toxicity in Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer

BACKGROUND: Docetaxel plus androgen deprivation therapy (ADT) offers a survival benefit in metastatic hormone-sensitive prostate cancer (mHSPC). However, one trial evaluating docetaxel in mHSPC (GETUG-AFU15) showed unexpected toxicity; raising concerns that docetaxel may carry increased toxicity whe...

詳細記述

保存先:
書誌詳細
出版年:Med Oncol
主要な著者: Schweizer, Michael T., Gulati, Roman, Mostaghel, Elahe A., Nelson, Peter S., Montgomery, R. Bruce, Yu, Evan Y., Cheng, Heather H.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5298886/
https://ncbi.nlm.nih.gov/pubmed/27300548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-016-0793-1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!